Coloplast A/S
Coloplast A/S (CLPBF) Stock Overview
Explore Coloplast A/S’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.4B
P/E Ratio
23.21
EPS (TTM)
$2.78
ROE
0.25%
CLPBF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Coloplast A/S (CLPBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.99, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $78.95.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.21 and a market capitalization of 13.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.